tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bill Maughan, 78 are a BUY (85.71%), 13 are a HOLD (14.29%).
Analyst Bill Maughan, currently employed at CANACCORD, carries an average stock price target met ratio of 36.05% that have a potential upside of 69.04% achieved within 140 days. Previously, Bill Maughan worked at TD COWEN.
Bill Maughan’s has documented 177 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BNTX, BioNTech SE at 06-May-2026.
Analyst best performing recommendations are on NKTX (NKARTA).
The best stock recommendation documented was for NKTX (NKARTA) at 10/17/2023. The price target of $15 was fulfilled within 141 days with a profit of $11.86 (377.71%) receiving and performance score of 26.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Dec-2021
$32
$17.58 (121.91%)
$30
2 months 21 days ago
(07-Aug-2026)
3/18 (16.67%)
$16.89 (111.78%)
716
Buy Since 05-Jan-2021
$21
$6.58 (45.63%)
$19
2 months 22 days ago
(06-Aug-2026)
4/12 (33.33%)
$5.53 (35.75%)
291
Buy Since 28-Jun-2024
$18
$3.58 (24.83%)
$20
8 months 1 days ago
(27-Feb-2026)
1/4 (25%)
$9.1 (102.25%)
325
Buy Since 26-Jul-2022
$27
$12.58 (87.24%)
$26
8 months 2 days ago
(26-Feb-2026)
2/6 (33.33%)
$18 (200.00%)
907
Buy Since 14-May-2024
$18
$5.06 (39.10%)
$25
11 months 23 days ago
(05-Nov-2025)
0/4 (0%)
$9.32 (107.37%)
Which stock is Bill Maughan most bullish on?
What Year was the first public recommendation made by Bill Maughan?
